I second that train of thought !!!

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Stock2740

Rank: Treasurer [?]

Points: 330 [?]

Votes: 10 Score: 2.2 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

I second that train of thought !!!

posted on Dec 01, 2015 11:20AM

We are on track , fueled with rumors of IPO ... In my Humble Opinion the train is picking up speed and first quarter of 2016 is fast approaching ... Will it be the orphan trial commencement, Kidney disease research trial or another regional deal within the fold ? First quarter should be exciting ...

" Dr. Kam Kalantar-Zadeh, Professor and Chief, Division of Nephrology and Hypertension at University of California in Irvine and Los Angeles stated, "Selective BET inhibition via RVX-208 may represent a novel approach to CKD treatment. Analyses of the data from recent clinical trials suggest that RVX-208 significantly lowers serum alkaline phosphatase (ALP) and improves lipid parameters in patients with CKD. "

Kidney research is going to be very promising "ALP" Treatment standard care therapy go RVX Go !!!